ResearcherSun Yat-sen UniversityNo recent work listed

Peng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0102-4544; OpenAlex author ID A5100395961. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 2 papers

Papers 2

Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase. Co-author DOI 10.1186/s40880-015-0012-z ↗
Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. Co-author DOI 10.18632/oncotarget.4125 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peng Huang · 2 shared papers, 2015 · strength 0.11
- Paper Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase. DOI 10.1186/s40880-015-0012-z ↗
- Paper Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. DOI 10.18632/oncotarget.4125 ↗
Yumin Hu · 2 shared papers, 2015 · strength 0.11
- Paper Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase. DOI 10.1186/s40880-015-0012-z ↗
- Paper Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. DOI 10.18632/oncotarget.4125 ↗
Yi-Chen Sun · 1 shared paper, 2015 · strength 0.06
- Paper Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase. DOI 10.1186/s40880-015-0012-z ↗
Gang Chen · 1 shared paper, 2015 · strength 0.05
- Paper Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. DOI 10.18632/oncotarget.4125 ↗
Paul J. Chiao · 1 shared paper, 2015 · strength 0.05
- Paper Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer. DOI 10.18632/oncotarget.4125 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.